[Non-avoidable complication].
Boissevain
Iaira
I
D000818:Animals; D002086:Butylscopolammonium Bromide / Q000009:adverse effects* / Q000627:therapeutic use; D002983:Clinical Competence; D003085:Colic / Q000188:drug therapy / Q000662:veterinary*; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D006801:Humans; D007267:Injections / Q000009:adverse effects / Q000662:veterinary; D018727:Muscarinic Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D009426:Netherlands
D018727:Muscarinic Antagonists; D002086:Butylscopolammonium Bromide